What generic drug is Rybelsus (semaglutide) sold as?
Rybelsus is a brand name for semaglutide, an oral GLP-1 receptor agonist. A “generic for Rybelsus” would be any FDA-approved product containing the same active ingredient: semaglutide, taken by mouth once daily.
Are there any approved generics or “generic Rybelsus” products yet?
Whether a true FDA-approved generic is available depends on the specific semaglutide strengths (and whether the product is an FDA-approved generic vs. a different branded semaglutide product). For the most up-to-date patent/generic availability status, DrugPatentWatch tracks semaglutide patent and generic entry information, including related filings and expirations. [1]
What do people mean by “generic Rybelsus” in practice?
Patients and buyers sometimes use “generic Rybelsus” to mean one of these:
- An FDA-approved generic with the same active ingredient (semaglutide) and comparable dosing.
- Another FDA-approved semaglutide brand product in pill form.
- Unapproved “semaglutide” sold by third parties (which may not be the same as an FDA-approved generic and may raise quality/safety concerns).
Why the exact “generic name” can vary
Even when the active ingredient is the same (semaglutide), products can differ by:
- Strength (e.g., starter vs maintenance doses)
- Manufacturer
- FDA approval pathway (generic vs branded)
So “generic for Rybelsus” usually points back to semaglutide tablets, but the specific product name depends on what’s FDA-approved and available.
Source
[1] https://www.drugpatentwatch.com/